Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

Neurology Minute by Anna Rehbein

In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that...View more